Norges Bank Invests $1.09 Million in Oscar Health, Inc. (NYSE:OSCR)

Norges Bank bought a new stake in Oscar Health, Inc. (NYSE:OSCR) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 80,738 shares of the company’s stock, valued at approximately $1,085,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of OSCR. BIT Capital GmbH grew its position in Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after acquiring an additional 4,396,872 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after purchasing an additional 8,051,379 shares during the period. Potentia Wealth purchased a new stake in shares of Oscar Health during the 4th quarter worth about $141,000. Vanguard Group Inc. increased its position in Oscar Health by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock worth $255,333,000 after purchasing an additional 586,626 shares in the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new position in Oscar Health in the fourth quarter valued at approximately $456,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Trading Up 2.8 %

OSCR opened at $12.59 on Friday. The firm has a market capitalization of $3.15 billion, a P/E ratio of -629.19 and a beta of 1.75. The firm’s 50 day moving average is $14.02 and its 200-day moving average is $15.35. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52-week low of $11.47 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Oscar Health has an average rating of “Hold” and an average target price of $20.21.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.